EDBI invests in Tessa Therapeutics
Clients EDBI Pte Ltd
Jones Day represented EDBI Pte. Ltd. in connection with its affiliate's purchase of stock in a private placement by Tessa Therapeutics Pte. Ltd., an international clinical stage biopharmaceutical company focusing on T cell therapy for solid tumors. Temasek, Karst Peak Capital, Heliconia Capital Management, and Heritas acted as co-investors in the $80 million investment round.